Cargando…
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425319/ https://www.ncbi.nlm.nih.gov/pubmed/35586965 http://dx.doi.org/10.3324/haematol.2021.280081 |
| _version_ | 1784778421663956992 |
|---|---|
| author | Rigaud, Charlotte Abbou, Samuel Ducasso, Stéphane Simonin, Mathieu Le Mouel, Lou Pereira, Victor Gourdon, Stéphanie Lambilliotte, Anne Geoerger, Birgit Minard-Colin, Véronique Brugières, Laurence |
| author_facet | Rigaud, Charlotte Abbou, Samuel Ducasso, Stéphane Simonin, Mathieu Le Mouel, Lou Pereira, Victor Gourdon, Stéphanie Lambilliotte, Anne Geoerger, Birgit Minard-Colin, Véronique Brugières, Laurence |
| author_sort | Rigaud, Charlotte |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9425319 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94253192022-09-15 Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement Rigaud, Charlotte Abbou, Samuel Ducasso, Stéphane Simonin, Mathieu Le Mouel, Lou Pereira, Victor Gourdon, Stéphanie Lambilliotte, Anne Geoerger, Birgit Minard-Colin, Véronique Brugières, Laurence Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-05-19 /pmc/articles/PMC9425319/ /pubmed/35586965 http://dx.doi.org/10.3324/haematol.2021.280081 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Rigaud, Charlotte Abbou, Samuel Ducasso, Stéphane Simonin, Mathieu Le Mouel, Lou Pereira, Victor Gourdon, Stéphanie Lambilliotte, Anne Geoerger, Birgit Minard-Colin, Véronique Brugières, Laurence Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title_full | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title_fullStr | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title_full_unstemmed | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title_short | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement |
| title_sort | profound and sustained response with next-generation alk inhibitors in patients with relapsed or progressive alk-positive anaplastic large cell lymphoma with central nervous system involvement |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425319/ https://www.ncbi.nlm.nih.gov/pubmed/35586965 http://dx.doi.org/10.3324/haematol.2021.280081 |
| work_keys_str_mv | AT rigaudcharlotte profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT abbousamuel profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT ducassostephane profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT simoninmathieu profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT lemouellou profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT pereiravictor profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT gourdonstephanie profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT lambilliotteanne profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT geoergerbirgit profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT minardcolinveronique profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement AT brugiereslaurence profoundandsustainedresponsewithnextgenerationalkinhibitorsinpatientswithrelapsedorprogressivealkpositiveanaplasticlargecelllymphomawithcentralnervoussysteminvolvement |